| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65d81f3bfccbc4def950db7637006935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_956ac3f1cd1c545edc675ef3c67af4d1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2016-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf508fd54dae7f80b201ecbbae1fb112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ad6fe11c0c5c1f96033b55d047c9ba9 |
| publicationDate |
2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9856481-B2 |
| titleOfInvention |
MicroRNA treatment of fibrosis |
| abstract |
Provided herein are microRNAs that target transforming growth factor beta (TGF-β) receptors and attenuate pathways of fibrosis. In particular, microRNA-1343 reduces expression of TGFBR1 and TGFBR2, decreases TGF-β signaling, represses pathways of fibrosis, and treats fibrotic diseases. |
| priorityDate |
2015-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |